Page last updated: 2024-11-02

pioglitazone and Hepatitis, Autoimmune

pioglitazone has been researched along with Hepatitis, Autoimmune in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Hepatitis, Autoimmune: A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Schulte, R1
Wohlleber, D1
Unrau, L1
Geers, B1
Metzger, C1
Erhardt, A1
Tiegs, G1
van Rooijen, N1
Heukamp, LC1
Klotz, L1
Knolle, PA1
Diehl, L1

Other Studies

1 other study available for pioglitazone and Hepatitis, Autoimmune

ArticleYear
Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
    International journal of molecular sciences, 2020, Apr-05, Volume: 21, Issue:7

    Topics: Animals; Cells, Cultured; Hepatitis, Autoimmune; Interferon-gamma; Kupffer Cells; Lymphocyte Activat

2020